Respirati
Respirati develops 5DCT technology to generate motion-artifact-free CT images of free-breathing patients for radiation therapy planning. This workflow replaces conventional 4DCT by providing accurate, quantified imaging that accounts for tumor motion. The technology aims to improve treatment planning, delivery, and patient outcomes in lung cancer radiation oncology.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Respirati develops 5DCT technology to generate motion-artifact-free CT images of free-breathing patients for radiation therapy planning. This workflow replaces conventional 4DCT by providing accurate, quantified imaging that accounts for tumor motion. The technology aims to improve treatment planning, delivery, and patient outcomes in lung cancer radiation oncology.